Pacific Biosciences of California Inc (PACB)

NASD · Healthcare · Medical Devices · USA

Pacific Biosciences of California Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.

Pacific Biosciences of California designs and manufactures sequencing systems using HiFi long-read technology that enable researchers to analyze genomes, transcriptomes, and epigenomes. The company serves academic institutions, research laboratories, hospitals, pharmaceutical companies, and agricultural organizations across applications including human genetics, infectious disease, oncology, and plant sciences. Its offerings comprise sequencing instruments, consumable chips and reagents, and bioinformatics workflows.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Pacific Biosciences of California Inc stock.

Our verdict on PACB

Not valued: We cannot value this company yet.

We do not publish a value for this company: a figure this valuation depends on is missing.

ETFs with the most weight in PACB

17 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than PACB in Medical Devices

61 more in this industry show a wider margin of safety.

Is PACB undervalued or overvalued?

We do not publish a verdict on PACB yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of PACB?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.